China Regenerative Medicine International Limited reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was HKD 54.05 million compared to HKD 51.92 million a year ago. Net income was HKD 1.57 million compared to HKD 1.12 million a year ago.

Basic earnings per share from continuing operations was HKD 0.0001 compared to HKD 0.0039 a year ago. Diluted earnings per share from continuing operations was HKD 0.0001 compared to HKD 0.0039 a year ago.